Social Innovation Technologies — DrugAlert.ai

DrugAlert.ai — predictive drug-trend intelligence

We aggregate and analyze drug tests with additional public-health signals to detect patterns, anomalies, and emerging poly-drug trends. The platform forecasts risk and alerts public health, hospitals, and law enforcement at the state, county, and ZIP levels.

Request a Demo
Fentanyl Carfentanil Methamphetamine Cocaine Xylazine Custom Panels
Signal-to-Alert
≤ 72 hours
Coverage to Come
50 states | 3,000+ counties
Precision
ZIP-level granularity
Delivery
Dashboards + email/SMS
Six-month positivity trend (sample)
Six-month positivity trend sample

How it works

DrugAlert.ai ingests laboratory test results and complementary sources such as EMS activity, hospital intake, and community programs to come. We compute co-positivity and anomaly scores, then run time-series and spatial models to predict near-term surges. When risk exceeds thresholds, stakeholders receive targeted alerts with location and substance details.

Aggregate
Secure pipelines (batch and stream). De-identification and governance built in.
Detect
Identify co-positivity patterns and velocity versus baselines.
Forecast
Short-horizon predictions at county and ZIP levels.
Alert
Dashboards and push notifications guiding response.

What it looks like

Dashboard with state heatmap and monthly positivity for selected drugs
Example dashboard showing a state heatmap with monthly positivity levels. Select a drug from the dropdown and drill from state to county to ZIP for granular analysis.

What you can do

  • Spot hotspots and unusual combinations such as fentanyl with xylazine.
  • Filter by substance panel, jurisdiction, and timeframe.
  • Export views for briefings and share role-based links.
  • Set alert thresholds tailored to local response capacity.
  • Compare month-over-month changes and visualize trend velocity.

Who it’s for

Public health teams, hospital leadership, and law enforcement analysts who need fast, localized intelligence to plan outreach and manage capacity.

Privacy-first, enterprise-grade

Single sign-on (SAML), least-privilege access, encryption in transit and at rest, audit logging, and strict data governance ensure safe handling of all structured and semi-structured data.

See DrugAlert.ai on your data

We'll configure a pilot, stand up dashboards, and show your leadership how predictive alerts improve planning and response.

Request a Demo